Kestra Advisory Services LLC trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 55.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,393 shares of the company’s stock after selling 80,047 shares during the period. Kestra Advisory Services LLC’s holdings in GE HealthCare Technologies were worth $4,275,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also added to or reduced their stakes in GEHC. Chicago Partners Investment Group LLC raised its holdings in shares of GE HealthCare Technologies by 1.9% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 7,246 shares of the company’s stock valued at $518,000 after purchasing an additional 133 shares in the last quarter. Carnegie Investment Counsel boosted its stake in shares of GE HealthCare Technologies by 2.0% during the third quarter. Carnegie Investment Counsel now owns 7,678 shares of the company’s stock valued at $502,000 after purchasing an additional 151 shares in the last quarter. Valeo Financial Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 3.5% during the third quarter. Valeo Financial Advisors LLC now owns 4,850 shares of the company’s stock valued at $317,000 after purchasing an additional 163 shares in the last quarter. Yousif Capital Management LLC increased its holdings in GE HealthCare Technologies by 0.4% during the third quarter. Yousif Capital Management LLC now owns 46,991 shares of the company’s stock valued at $3,072,000 after buying an additional 167 shares during the period. Finally, Sigma Planning Corp increased its holdings in GE HealthCare Technologies by 3.6% during the third quarter. Sigma Planning Corp now owns 5,152 shares of the company’s stock valued at $337,000 after buying an additional 178 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.
GE HealthCare Technologies Price Performance
Shares of NASDAQ GEHC opened at $83.02 on Monday. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company has a market cap of $37.54 billion, a PE ratio of 17.51, a P/E/G ratio of 2.09 and a beta of 0.64. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.01 and a current ratio of 1.30. The business has a 50-day simple moving average of $70.55 and a two-hundred day simple moving average of $70.11.
GE HealthCare Technologies Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Friday, October 23rd were given a dividend of $0.04 per share. The ex-dividend date of this dividend was Friday, October 23rd. This represents a $0.16 annualized dividend and a yield of 0.2%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s payout ratio is presently 3.38%.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on GEHC. Wolfe Research assumed coverage on GE HealthCare Technologies in a report on Tuesday, October 20th. They set a “peer perform” rating for the company. Evercore reaffirmed an “outperform” rating and set a $84.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, July 30th. Barclays lifted their price target on GE HealthCare Technologies from $85.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, October 29th. Zacks Research raised GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 11th. Finally, Argus upped their price objective on GE HealthCare Technologies from $85.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, November 11th. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $82.17.
View Our Latest Stock Report on GE HealthCare Technologies
About GE HealthCare Technologies
GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.
Featured Stories
- Five stocks we like better than GE HealthCare Technologies
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
